secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2026-10-06T20:30:16+00:00
Accession:  0001683168-26-007657
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 3.03, 5.03, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Sonoma Pharmaceuticals adopts Section 382 rights plan to protect NOLs, expiring Oct 6, 2036
--------------------------------------------------------------------------------

- Board approved a Section 382 rights agreement effective Oct 6, 2026 with Computershare Inc. as rights agent, replacing the Section 182 plan dated Oct 18, 2016 that expires Oct 18, 2026.
- One Right issued per share of common stock ($0.0001 par) outstanding on the Oct 13, 2026 record date; each Right buys 1/1000th of a share of Series B Preferred Stock at $10.00.
- Rights become exercisable if a person or group beneficially owns 4.99% or more of common stock; holders at 4.99%+ on Oct 6, 2026 are grandfathered up to a 0.5% increase.
- Rights expire the earlier of Oct 6, 2036 or when NOLs are exhausted, and are redeemable at $0.0001 per Right before a triggering event.
- Stated purpose: guard against an ownership change limiting Sonoma's net operating loss carryforwards, which it calls a substantial asset.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316826007657/0001683168-26-007657-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316826007657/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-007657

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer